<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34311603</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-2300</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of international medical research</Title><ISOAbbreviation>J Int Med Res</ISOAbbreviation></Journal><ArticleTitle>Glutathione S-transferase Omega 2 DD genotype is associated with an increased risk of sporadic amyotrophic lateral sclerosis in Chinese men.</ArticleTitle><Pagination><StartPage>3000605211033219</StartPage><MedlinePgn>3000605211033219</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">03000605211033219</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/03000605211033219</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether <i>GSTA1</i>, <i>GSTO2</i>, and <i>GSTZ1</i> are relevant to an increased risk of amyotrophic lateral sclerosis (ALS) in a Chinese population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, 143 sporadic ALS (sALS) patients (83 men, 60 women) and 210 age- and sex-matched healthy subjects were enrolled. Blood samples were collected by venipuncture. Genomic DNA was isolated by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) according to the manufacturer's instructions. The potential associations between ALS and <i>GSTA1</i>, <i>GSTO2</i>, and <i>GSTZ1</i> polymorphisms were estimated using chi-squared analysis and unconditional logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The D allele and genotype frequencies of <i>GSTO2</i> were increased in sALS patients compared with healthy subjects, indicating that the <i>GSTO2</i> DD genotype was associated with an increased risk of sALS (odds ratio [OR]&#x2009;=&#x2009;3.294, 95% confidence interval [CI]&#x2009;=&#x2009;1.039-10.448). However, a significant association between the DD genotype and the risk of sALS was evident in men only (OR&#x2009;=&#x2009;7.167, 95% CI&#x2009;=&#x2009;1.381-37.202).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study revealed that the D allele and genotype frequencies of <i>GSTO2</i> were increased in sALS patients. The <i>GSTO2</i> DD genotype was associated with an increased risk of sALS in men in a Chinese population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Zhiliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, 71213Second Hospital of Hebei Medical University, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Province Key Laboratory of Neurology, Institute of Cardiocerebrovascular Disease, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Third Department of Neurology, Xingtai People's Hospital, Xingtai, Hebei, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, 71213Second Hospital of Hebei Medical University, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Province Key Laboratory of Neurology, Institute of Cardiocerebrovascular Disease, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, 71213Second Hospital of Hebei Medical University, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Province Key Laboratory of Neurology, Institute of Cardiocerebrovascular Disease, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yansu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, 71213Second Hospital of Hebei Medical University, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Province Key Laboratory of Neurology, Institute of Cardiocerebrovascular Disease, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xinying</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-6176-6438</Identifier><AffiliationInfo><Affiliation>Department of Neurology, 71213Second Hospital of Hebei Medical University, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Province Key Laboratory of Neurology, Institute of Cardiocerebrovascular Disease, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Int Med Res</MedlineTA><NlmUniqueID>0346411</NlmUniqueID><ISSNLinking>0300-0605</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.5.1.-</RegistryNumber><NameOfSubstance UI="C407705">GSTZ1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="C484555">GSTA1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="C492569">GSTO2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005982" MajorTopicYN="Y">Glutathione Transferase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Chinese</Keyword><Keyword MajorTopicYN="N">GSTA1</Keyword><Keyword MajorTopicYN="N">GSTO2</Keyword><Keyword MajorTopicYN="N">GSTZ1</Keyword><Keyword MajorTopicYN="N">genetic polymorphism</Keyword></KeywordList><CoiStatement><b>Declaration of conflicting interest:</b> The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34311603</ArticleId><ArticleId IdType="pmc">PMC8320566</ArticleId><ArticleId IdType="doi">10.1177/03000605211033219</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Paula CZ, Goncalves BD, Vieira LB. An overview of potential targets for treating amyotrophic lateral sclerosis and Huntington's disease. Biomed Res Int. 2015; 2015: 198612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532815</ArticleId><ArticleId IdType="pubmed">26295035</ArticleId></ArticleIdList></Reference><Reference><Citation>Navone F, Genevini P, Borgese N. Autophagy and neurodegeneration: insights from a cultured cell model of ALS. Cells 2015; 4: 354&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4588041</ArticleId><ArticleId IdType="pubmed">26287246</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Kukreti R, Saso L, et al. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 2019; 24: 1583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Raunio H, Husgafvel-Pursiainen K, Anttila S, et al.. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility&#x2013;a review. Gene 1995; 159: 113&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">7607565</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajewska B, Kazmierczak B, Kuzma-Kozakiewicz M, et al.. GSTP1 Polymorphisms and their association with glutathione transferase and peroxidase activities in patients with motor neuron disease. CNS Neurol Disord Drug Targets 2015; 14: 1328&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">26295823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg G, Smolenski S, Hattis D, et al.. Genetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev 2009; 12: 389&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">20183528</ArticleId></ArticleIdList></Reference><Reference><Citation>Coles BF, Morel F, Rauch C, et al.. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001; 11: 663&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">11692074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ercegovac M, Jovic N, Sokic D, et al.. GSTA1, GSTM1, GSTP1 and GSTT1 polymorphisms in progressive myoclonus epilepsy: a Serbian case-control study. Seizure 2015; 32: 30&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">26552558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zare MSSJ, Mehdipur P, Abedinejad M, et al.. The influence of CYP1A1 and GSTM1 polymorphism on the concentration of urinary 1-hydroxypyrene in cPAHs exposed Iranian anode plant workers. Molecular &amp; Cellular Toxicology 2013; 9: 303&#x2013;309.</Citation></Reference><Reference><Citation>Kim I, Keam B, Lee KH, et al.. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Clin Transplant 2007; 21: 207&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">17425746</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitbread AK, Tetlow N, Eyre HJ, et al.. Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 2003; 13: 131&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">12618591</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoudi M, Saadat I, Omidvari S, et al.. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 2009; 36: 781&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">18398695</ArticleId></ArticleIdList></Reference><Reference><Citation>Menegon A, Board PG, Blackburn AC, et al.. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998; 352: 1344&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pubmed">9802272</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong G, James MO, Smeltz MG, et al.. Age-related changes in expression and activity of human hepatic mitochondrial glutathione transferase zeta1. Drug Metab Dispos 2018; 46: 1118&#x2013;1128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6038028</ArticleId><ArticleId IdType="pubmed">29853471</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005; 45: 51&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">15822171</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D, Rasi S, Franceschetti S, et al.. Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21. Leukemia. 2009; 23: 1118&#x2013;1126.</Citation><ArticleIdList><ArticleId IdType="pubmed">19448608</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhdar H, El Shamieh S, Musso O, et al.. The rs3957357C&gt;T SNP in GSTA1 is associated with a higher risk of occurrence of hepatocellular carcinoma in European individuals. PLoS One. 2016; 11: e0167543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5147914</ArticleId><ArticleId IdType="pubmed">27936036</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn AC, Coggan M, Tzeng HF, et al. . GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase. Pharmacogenetics. 2001; 11: 671&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pubmed">11692075</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn AC, Tzeng HF, Anders MW, et al. . Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis. Pharmacogenetics. 2000; 10: 49&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">10739172</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroads AL, Langaee T, Coats BS, et al.. Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate. J Clin Pharmacol. 2012; 52: 837&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786668</ArticleId><ArticleId IdType="pubmed">21642471</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147: 573&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Giessen E, Fogh I, Gopinath S, et al.. Association study on glutathione S-transferase omega 1 and 2 and familial ALS. Amyotroph Lateral Scler 2008; 9: 81&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">18427999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzma M, Jamrozik Z, Baranczyk-Kuzma A. Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis. Clin Chim Acta 2006; 364: 217&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">16109392</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Bosque-Varela P, Perez-pereda S, et al.. The increasing importance of environmental conditions in amyotrophic lateral sclerosis. Int J Biometeorol. 2018; 62: 1361&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pubmed">29713861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufir&#xed;a M, Gil-Bea FJ, Fern&#xe1;ndez-Torr&#xf3;n R, et al.. ALS: a bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol. 2016; 142: 104&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado Lde G, Bicalho ICS, Vidigal-Lopes M, et al.. Amyotrophic lateral sclerosis in Brazil: case series and review of the Brazilian literature. Amyotroph Lateral Scler Frontotemporal Degener. 2016; 17: 282&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">26854959</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney JPK, Visser AE, D'Ovidio F, et al.. A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR. Neurology. 2017; 89: 1283&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pubmed">28835399</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasconcelos K, Oliveira ASB, Fuchs LFP, et al.. Estrogens: possible protection against amyotrophic lateral sclerosis? Rev Assoc Med Bras (1992). 2019; 65: 576&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">31166428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T. Glutathione S-transferases variants as risk factors in Alzheimer's disease. Neurol Sci. 2015; 36: 1785&#x2013;1792.</Citation><ArticleIdList><ArticleId IdType="pubmed">25981226</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmuck EM, Board PG, Whitbread AK, et al.. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases. Pharmacogenet Genomics. 2005; 15: 493&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">15970797</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YJ, Oliveira SA, Xu P, et al.. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Gen. 2003; 12: 3259&#x2013;3267.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570706</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitbread A, Mellick GD, Silburn PA, et al.. Glutathione transferase Omega class polymorphisms in Parkinson disease. Neurology. 2004; 62: 1910&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pubmed">15159516</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>